Benjamin Edwards’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
Other funds holding REGN
Benjamin Edwards's REGN Position: Q3 2026 in Review
Benjamin Edwards reduced its Regeneron Pharmaceuticals (REGN) stake by 2.8% in Q3 2026, selling an estimated $55.9K and leaving 2,539 shares worth $1.93M. The position accounts for 0.02% of the portfolio, ranked #582.
Benjamin Edwards first reported a position in REGN in Q1 2021 and has held it in 20 quarters since. The position peaked at $3.32M in Q4 2025. 1,212 funds tracked by Wall St. Rank hold REGN as of Q3 2026.
- Benjamin Edwards held 2,539 shares of Regeneron Pharmaceuticals worth $1.93M as of Q3 2026.
- Benjamin Edwards sold 74 Regeneron Pharmaceuticals shares in Q3 2026, an estimated $55.9K.
- Regeneron Pharmaceuticals made up 0.02% of Benjamin Edwards's portfolio in Q3 2026, its #582 holding.
- Benjamin Edwards first reported a position in Regeneron Pharmaceuticals in Q1 2021 and has held it in 20 quarters since.
- Benjamin Edwards's Regeneron Pharmaceuticals position peaked at $3.32M in Q4 2025.
- 1,212 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q3 2026.
Based on Benjamin Edwards's 13F filing for Q3 2026, filed 12 Nov 2026.